Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peg-IFN-α and Tenofovir in HBV-related Liver Fibrosis
NCT04640129Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2021
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in hepatitis B (HBV), Liver Fibrosis (LF), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Started Jan 2021; status: recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis B (HBV)Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT04640129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04640129.